| 0 (0%) | 09-27 09:34 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 16.8 | 1-year : | 17.81 |
| Resists | First : | 14.38 | Second : | 15.25 |
| Pivot price | 13.56  |
|||
| Supports | First : | 12.99 | Second : | 10.81 |
| MAs | MA(5) : | 13.2 |
MA(20) : | 13.76 |
| MA(100) : | 15.3 |
MA(250) : | 15.22 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 8.4 |
D(3) : | 7.5 |
| RSI | RSI(14): 36.7 |
|||
| 52-week | High : | 18.88 | Low : | 11.81 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ BV ] has closed above bottom band by 30.2%. Bollinger Bands are 20.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 13.37 - 13.45 | 13.45 - 13.52 |
| Low: | 12.81 - 12.9 | 12.9 - 13 |
| Close: | 13.13 - 13.27 | 13.27 - 13.41 |
Fri, 26 Sep 2025
Meet the BV School Board Candidate: Casey Martin – At Large - Ark Valley Voice
Thu, 25 Sep 2025
Admesy BV - Photonics Spectra
Thu, 25 Sep 2025
BV Playground Reinvigorated - thenews-gazette.com
Thu, 25 Sep 2025
SFI Health™ EMEA Announces Exclusive License Agreement with Curasense BV for Equazen - Business Wire
Wed, 24 Sep 2025
LuxExperience BV (LUXE) Q4 2025 Earnings Report Preview: What to Expect - Yahoo Finance
Thu, 31 Jul 2025
Everything you need to know about bacterial vaginosis (BV) but might not want to ask - Novant Health
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 95 (M) |
| Shares Float | 71 (M) |
| Held by Insiders | 2.9 (%) |
| Held by Institutions | 108.1 (%) |
| Shares Short | 4,870 (K) |
| Shares Short P.Month | 5,220 (K) |
| EPS | 0.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.47 |
| Profit Margin | 2 % |
| Operating Margin | 8.7 % |
| Return on Assets (ttm) | 3 % |
| Return on Equity (ttm) | 3 % |
| Qtrly Rev. Growth | -4.1 % |
| Gross Profit (p.s.) | 6.61 |
| Sales Per Share | 28.45 |
| EBITDA (p.s.) | 3.4 |
| Qtrly Earnings Growth | 52.5 % |
| Operating Cash Flow | 261 (M) |
| Levered Free Cash Flow | 65 (M) |
| PE Ratio | 110.66 |
| PEG Ratio | 0 |
| Price to Book value | 0.98 |
| Price to Sales | 0.46 |
| Price to Cash Flow | 4.83 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|